It has been found that specific mutations or changes in expression of TP53 are correlated with LNM in various cutaneous squamous cell carcinomas (36–38), and alterations in TP53 were significantly associated with shorter event-free survival (10). The gene discussed is TP53; the disease is cutaneous squamous cell carcinoma.